SIRT2	B:C2720168
Deacetylates	O
and	O
Inhibits	O
the	I:C3893923
Peroxidase	I:C3893923
Activity	I:C3893923
of	O
Peroxiredoxin	O
-	I:C0672553
1	I:C0672553
to	O
Sensitize	O
Breast	I:C1512505
Cancer	I:C1512505
Cells	I:C1512505
to	O
Oxidant	O
Stress	I:C0242606
-	O
Inducing	O
Agents	O
.	O

SIRT2	O
Deacetylates	B:C2246982
and	O
Inhibits	O
the	I:C3893923
Peroxidase	I:C3893923
Activity	I:C3893923
of	O
Peroxiredoxin	O
-	I:C0672553
1	I:C0672553
to	O
Sensitize	O
Breast	I:C1512505
Cancer	I:C1512505
Cells	I:C1512505
to	O
Oxidant	O
Stress	I:C0242606
-	O
Inducing	O
Agents	O
.	O

SIRT2	O
Deacetylates	O
and	O
Inhibits	B:C3893923
the	I:C3893923
Peroxidase	I:C3893923
Activity	I:C3893923
of	O
Peroxiredoxin	O
-	I:C0672553
1	I:C0672553
to	O
Sensitize	O
Breast	I:C1512505
Cancer	I:C1512505
Cells	I:C1512505
to	O
Oxidant	O
Stress	I:C0242606
-	O
Inducing	O
Agents	O
.	O

SIRT2	O
Deacetylates	O
and	O
Inhibits	O
the	I:C3893923
Peroxidase	I:C3893923
Activity	I:C3893923
of	O
Peroxiredoxin	B:C0672553
-	I:C0672553
1	I:C0672553
to	O
Sensitize	O
Breast	I:C1512505
Cancer	I:C1512505
Cells	I:C1512505
to	O
Oxidant	O
Stress	I:C0242606
-	O
Inducing	O
Agents	O
.	O

SIRT2	O
Deacetylates	O
and	O
Inhibits	O
the	I:C3893923
Peroxidase	I:C3893923
Activity	I:C3893923
of	O
Peroxiredoxin	O
-	I:C0672553
1	I:C0672553
to	O
Sensitize	B:C1512505
Breast	I:C1512505
Cancer	I:C1512505
Cells	I:C1512505
to	O
Oxidant	O
Stress	I:C0242606
-	O
Inducing	O
Agents	O
.	O

SIRT2	O
Deacetylates	O
and	O
Inhibits	O
the	I:C3893923
Peroxidase	I:C3893923
Activity	I:C3893923
of	O
Peroxiredoxin	O
-	I:C0672553
1	I:C0672553
to	O
Sensitize	O
Breast	I:C1512505
Cancer	I:C1512505
Cells	I:C1512505
to	O
Oxidant	B:C0242606
Stress	I:C0242606
-	O
Inducing	O
Agents	O
.	O

SIRT2	B:C2720168
is	O
a	O
protein	O
deacetylase	I:C2246982
with	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
in	O
breast	O
and	O
liver	O
tumors	I:C0345904
where	O
it	O
is	O
mutated	O
;	O
however	O
,	O
the	O
critical	O
substrates	O
mediating	O
its	O
antitumor	O
activity	I:C0243095
are	O
not	O
fully	O
defined	O
.	O

SIRT2	O
is	O
a	O
protein	B:C2246982
deacetylase	I:C2246982
with	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
in	O
breast	O
and	O
liver	O
tumors	I:C0345904
where	O
it	O
is	O
mutated	O
;	O
however	O
,	O
the	O
critical	O
substrates	O
mediating	O
its	O
antitumor	O
activity	I:C0243095
are	O
not	O
fully	O
defined	O
.	O

SIRT2	O
is	O
a	O
protein	O
deacetylase	I:C2246982
with	O
tumor	B:C1325410
suppressor	I:C1325410
activity	I:C1325410
in	O
breast	O
and	O
liver	O
tumors	I:C0345904
where	O
it	O
is	O
mutated	O
;	O
however	O
,	O
the	O
critical	O
substrates	O
mediating	O
its	O
antitumor	O
activity	I:C0243095
are	O
not	O
fully	O
defined	O
.	O

SIRT2	O
is	O
a	O
protein	O
deacetylase	I:C2246982
with	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
in	O
breast	B:C0006142
and	O
liver	O
tumors	I:C0345904
where	O
it	O
is	O
mutated	O
;	O
however	O
,	O
the	O
critical	O
substrates	O
mediating	O
its	O
antitumor	O
activity	I:C0243095
are	O
not	O
fully	O
defined	O
.	O

SIRT2	O
is	O
a	O
protein	O
deacetylase	I:C2246982
with	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
in	O
breast	O
and	O
liver	B:C0345904
tumors	I:C0345904
where	O
it	O
is	O
mutated	O
;	O
however	O
,	O
the	O
critical	O
substrates	O
mediating	O
its	O
antitumor	O
activity	I:C0243095
are	O
not	O
fully	O
defined	O
.	O

SIRT2	O
is	O
a	O
protein	O
deacetylase	I:C2246982
with	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
in	O
breast	O
and	O
liver	O
tumors	I:C0345904
where	O
it	O
is	O
mutated	B:C1705285
;	O
however	O
,	O
the	O
critical	O
substrates	O
mediating	O
its	O
antitumor	O
activity	I:C0243095
are	O
not	O
fully	O
defined	O
.	O

SIRT2	O
is	O
a	O
protein	O
deacetylase	I:C2246982
with	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
in	O
breast	O
and	O
liver	O
tumors	I:C0345904
where	O
it	O
is	O
mutated	O
;	O
however	O
,	O
the	O
critical	O
substrates	O
mediating	O
its	O
antitumor	B:C0243095
activity	I:C0243095
are	O
not	O
fully	O
defined	O
.	O

Here	O
we	O
demonstrate	O
that	O
SIRT2	B:C2720168
binds	O
,	O
deacetylates	O
,	O
and	O
inhibits	O
the	I:C3893923
peroxidase	I:C3893923
activity	I:C3893923
of	O
the	O
antioxidant	O
protein	I:C0672553
peroxiredoxin	I:C0672553
(	O
Prdx	O
-	I:C0672553
1	I:C0672553
)	O
in	O
breast	O
cancer	I:C1512505
cells	I:C1512505
.	O

Here	O
we	O
demonstrate	O
that	O
SIRT2	O
binds	B:C1149286
,	O
deacetylates	O
,	O
and	O
inhibits	O
the	I:C3893923
peroxidase	I:C3893923
activity	I:C3893923
of	O
the	O
antioxidant	O
protein	I:C0672553
peroxiredoxin	I:C0672553
(	O
Prdx	O
-	I:C0672553
1	I:C0672553
)	O
in	O
breast	O
cancer	I:C1512505
cells	I:C1512505
.	O

Here	O
we	O
demonstrate	O
that	O
SIRT2	O
binds	O
,	O
deacetylates	B:C1511737
,	O
and	O
inhibits	O
the	I:C3893923
peroxidase	I:C3893923
activity	I:C3893923
of	O
the	O
antioxidant	O
protein	I:C0672553
peroxiredoxin	I:C0672553
(	O
Prdx	O
-	I:C0672553
1	I:C0672553
)	O
in	O
breast	O
cancer	I:C1512505
cells	I:C1512505
.	O

Here	O
we	O
demonstrate	O
that	O
SIRT2	O
binds	O
,	O
deacetylates	O
,	O
and	O
inhibits	B:C3893923
the	I:C3893923
peroxidase	I:C3893923
activity	I:C3893923
of	O
the	O
antioxidant	O
protein	I:C0672553
peroxiredoxin	I:C0672553
(	O
Prdx	O
-	I:C0672553
1	I:C0672553
)	O
in	O
breast	O
cancer	I:C1512505
cells	I:C1512505
.	O

Here	O
we	O
demonstrate	O
that	O
SIRT2	O
binds	O
,	O
deacetylates	O
,	O
and	O
inhibits	O
the	I:C3893923
peroxidase	I:C3893923
activity	I:C3893923
of	O
the	O
antioxidant	B:C0672553
protein	I:C0672553
peroxiredoxin	I:C0672553
(	O
Prdx	O
-	I:C0672553
1	I:C0672553
)	O
in	O
breast	O
cancer	I:C1512505
cells	I:C1512505
.	O

Here	O
we	O
demonstrate	O
that	O
SIRT2	O
binds	O
,	O
deacetylates	O
,	O
and	O
inhibits	O
the	I:C3893923
peroxidase	I:C3893923
activity	I:C3893923
of	O
the	O
antioxidant	O
protein	I:C0672553
peroxiredoxin	I:C0672553
(	O
Prdx	B:C0672553
-	I:C0672553
1	I:C0672553
)	O
in	O
breast	O
cancer	I:C1512505
cells	I:C1512505
.	O

Here	O
we	O
demonstrate	O
that	O
SIRT2	O
binds	O
,	O
deacetylates	O
,	O
and	O
inhibits	O
the	I:C3893923
peroxidase	I:C3893923
activity	I:C3893923
of	O
the	O
antioxidant	O
protein	I:C0672553
peroxiredoxin	I:C0672553
(	O
Prdx	O
-	I:C0672553
1	I:C0672553
)	O
in	O
breast	B:C1512505
cancer	I:C1512505
cells	I:C1512505
.	O

Ectopic	B:C0574895
overexpression	O
of	O
SIRT2	O
,	O
but	O
not	O
its	O
catalytically	O
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	O
levels	I:C0178719
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
induced	O
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	O
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	O
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Ectopic	O
overexpression	B:C0017262
of	O
SIRT2	O
,	O
but	O
not	O
its	O
catalytically	O
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	O
levels	I:C0178719
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
induced	O
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	O
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	O
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Ectopic	O
overexpression	O
of	O
SIRT2	B:C2720168
,	O
but	O
not	O
its	O
catalytically	O
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	O
levels	I:C0178719
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
induced	O
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	O
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	O
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Ectopic	O
overexpression	O
of	O
SIRT2	O
,	O
but	O
not	O
its	O
catalytically	B:C0596988
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	O
levels	I:C0178719
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
induced	O
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	O
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	O
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Ectopic	O
overexpression	O
of	O
SIRT2	O
,	O
but	O
not	O
its	O
catalytically	O
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	B:C0178719
levels	I:C0178719
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
induced	O
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	O
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	O
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Ectopic	O
overexpression	O
of	O
SIRT2	O
,	O
but	O
not	O
its	O
catalytically	O
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	O
levels	I:C0178719
of	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
induced	O
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	O
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	O
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Ectopic	O
overexpression	O
of	O
SIRT2	O
,	O
but	O
not	O
its	O
catalytically	O
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	O
levels	I:C0178719
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
)	O
induced	O
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	O
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	O
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Ectopic	O
overexpression	O
of	O
SIRT2	O
,	O
but	O
not	O
its	O
catalytically	O
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	O
levels	I:C0178719
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
induced	B:C0020281
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	O
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	O
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Ectopic	O
overexpression	O
of	O
SIRT2	O
,	O
but	O
not	O
its	O
catalytically	O
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	O
levels	I:C0178719
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
induced	O
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	B:C0672553
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	O
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Ectopic	O
overexpression	O
of	O
SIRT2	O
,	O
but	O
not	O
its	O
catalytically	O
dead	I:C0596988
mutant	I:C0596988
,	O
increased	O
intracellular	O
levels	I:C0178719
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
induced	O
by	I:C0020281
hydrogen	I:C0020281
peroxide	I:C0020281
,	I:C0020281
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
overoxidized	O
and	I:C0672553
multimeric	I:C0672553
form	I:C0672553
of	I:C0672553
Prdx	I:C0672553
-	I:C0672553
1	I:C0672553
with	O
activity	B:C0243041
as	I:C0243041
a	I:C0243041
molecular	I:C0243041
chaperone	I:C0243041
.	O

Elevated	O
levels	O
of	O
SIRT2	B:C1420071
sensitized	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
intracellular	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
death	I:C3894015
induced	I:C3894015
by	I:C3894015
oxidative	I:C3894015
stress	I:C3894015
,	O
as	O
associated	O
with	O
increased	O
levels	O
of	O
nuclear	O
FOXO3A	I:C1333633
and	O
the	O
proapoptotic	O
BIM	I:C4282114
protein	I:C4282114
.	O

Elevated	O
levels	O
of	O
SIRT2	O
sensitized	B:C1512505
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
intracellular	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
death	I:C3894015
induced	I:C3894015
by	I:C3894015
oxidative	I:C3894015
stress	I:C3894015
,	O
as	O
associated	O
with	O
increased	O
levels	O
of	O
nuclear	O
FOXO3A	I:C1333633
and	O
the	O
proapoptotic	O
BIM	I:C4282114
protein	I:C4282114
.	O

Elevated	O
levels	O
of	O
SIRT2	O
sensitized	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
intracellular	B:C0012860
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
death	I:C3894015
induced	I:C3894015
by	I:C3894015
oxidative	I:C3894015
stress	I:C3894015
,	O
as	O
associated	O
with	O
increased	O
levels	O
of	O
nuclear	O
FOXO3A	I:C1333633
and	O
the	O
proapoptotic	O
BIM	I:C4282114
protein	I:C4282114
.	O

Elevated	O
levels	O
of	O
SIRT2	O
sensitized	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
intracellular	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	B:C3894015
death	I:C3894015
induced	I:C3894015
by	I:C3894015
oxidative	I:C3894015
stress	I:C3894015
,	O
as	O
associated	O
with	O
increased	O
levels	O
of	O
nuclear	O
FOXO3A	I:C1333633
and	O
the	O
proapoptotic	O
BIM	I:C4282114
protein	I:C4282114
.	O

Elevated	O
levels	O
of	O
SIRT2	O
sensitized	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
intracellular	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
death	I:C3894015
induced	I:C3894015
by	I:C3894015
oxidative	I:C3894015
stress	I:C3894015
,	O
as	O
associated	O
with	O
increased	O
levels	O
of	O
nuclear	B:C1333633
FOXO3A	I:C1333633
and	O
the	O
proapoptotic	O
BIM	I:C4282114
protein	I:C4282114
.	O

Elevated	O
levels	O
of	O
SIRT2	O
sensitized	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
intracellular	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
death	I:C3894015
induced	I:C3894015
by	I:C3894015
oxidative	I:C3894015
stress	I:C3894015
,	O
as	O
associated	O
with	O
increased	O
levels	O
of	O
nuclear	O
FOXO3A	I:C1333633
and	O
the	O
proapoptotic	B:C4282114
BIM	I:C4282114
protein	I:C4282114
.	O

In	O
addition	O
,	O
elevated	O
levels	O
of	O
SIRT2	B:C2720168
sensitized	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
arsenic	O
trioxide	I:C0052416
,	O
an	O
approved	O
therapeutic	O
agent	O
,	O
along	O
with	O
other	O
intracellular	O
ROS	I:C0162772
-	O
inducing	O
agents	I:C1254351
.	O

In	O
addition	O
,	O
elevated	O
levels	O
of	O
SIRT2	O
sensitized	B:C1512505
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
arsenic	O
trioxide	I:C0052416
,	O
an	O
approved	O
therapeutic	O
agent	O
,	O
along	O
with	O
other	O
intracellular	O
ROS	I:C0162772
-	O
inducing	O
agents	I:C1254351
.	O

In	O
addition	O
,	O
elevated	O
levels	O
of	O
SIRT2	O
sensitized	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
arsenic	B:C0052416
trioxide	I:C0052416
,	O
an	O
approved	O
therapeutic	O
agent	O
,	O
along	O
with	O
other	O
intracellular	O
ROS	I:C0162772
-	O
inducing	O
agents	I:C1254351
.	O

In	O
addition	O
,	O
elevated	O
levels	O
of	O
SIRT2	O
sensitized	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
arsenic	O
trioxide	I:C0052416
,	O
an	O
approved	O
therapeutic	O
agent	O
,	O
along	O
with	O
other	O
intracellular	B:C0162772
ROS	I:C0162772
-	O
inducing	O
agents	I:C1254351
.	O

In	O
addition	O
,	O
elevated	O
levels	O
of	O
SIRT2	O
sensitized	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
arsenic	O
trioxide	I:C0052416
,	O
an	O
approved	O
therapeutic	O
agent	O
,	O
along	O
with	O
other	O
intracellular	O
ROS	I:C0162772
-	O
inducing	B:C1254351
agents	I:C1254351
.	O

Conversely	O
,	O
antisense	B:C0080124
RNA	I:C0080124
-	O
mediated	O
attenuation	O
of	O
SIRT2	O
reversed	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
toxicity	I:C1516457
as	O
demonstrated	O
in	O
a	O
zebrafish	O
embryo	O
model	I:C0013935
system	I:C0013935
.	O

Conversely	O
,	O
antisense	O
RNA	I:C0080124
-	O
mediated	O
attenuation	O
of	O
SIRT2	B:C2720168
reversed	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
toxicity	I:C1516457
as	O
demonstrated	O
in	O
a	O
zebrafish	O
embryo	O
model	I:C0013935
system	I:C0013935
.	O

Conversely	O
,	O
antisense	O
RNA	I:C0080124
-	O
mediated	O
attenuation	O
of	O
SIRT2	O
reversed	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
toxicity	I:C1516457
as	O
demonstrated	O
in	O
a	O
zebrafish	O
embryo	O
model	I:C0013935
system	I:C0013935
.	O

Conversely	O
,	O
antisense	O
RNA	I:C0080124
-	O
mediated	O
attenuation	O
of	O
SIRT2	O
reversed	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	B:C1516457
toxicity	I:C1516457
as	O
demonstrated	O
in	O
a	O
zebrafish	O
embryo	O
model	I:C0013935
system	I:C0013935
.	O

Conversely	O
,	O
antisense	O
RNA	I:C0080124
-	O
mediated	O
attenuation	O
of	O
SIRT2	O
reversed	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
toxicity	I:C1516457
as	O
demonstrated	O
in	O
a	O
zebrafish	B:C0043457
embryo	O
model	I:C0013935
system	I:C0013935
.	O

Conversely	O
,	O
antisense	O
RNA	I:C0080124
-	O
mediated	O
attenuation	O
of	O
SIRT2	O
reversed	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
toxicity	I:C1516457
as	O
demonstrated	O
in	O
a	O
zebrafish	O
embryo	B:C0013935
model	I:C0013935
system	I:C0013935
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	B:C1325410
suppressor	I:C1325410
activity	I:C1325410
of	O
SIRT2	O
requires	O
its	O
ability	O
to	O
restrict	O
the	O
antioxidant	O
activity	I:C1148564
of	O
Prdx	O
-	I:C0672553
1	I:C0672553
,	O
thereby	O
sensitizing	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
cytotoxicity	I:C0596402
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
of	O
SIRT2	B:C2720168
requires	O
its	O
ability	O
to	O
restrict	O
the	O
antioxidant	O
activity	I:C1148564
of	O
Prdx	O
-	I:C0672553
1	I:C0672553
,	O
thereby	O
sensitizing	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
cytotoxicity	I:C0596402
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
of	O
SIRT2	O
requires	O
its	O
ability	O
to	O
restrict	O
the	O
antioxidant	B:C1148564
activity	I:C1148564
of	O
Prdx	O
-	I:C0672553
1	I:C0672553
,	O
thereby	O
sensitizing	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
cytotoxicity	I:C0596402
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
of	O
SIRT2	O
requires	O
its	O
ability	O
to	O
restrict	O
the	O
antioxidant	O
activity	I:C1148564
of	O
Prdx	B:C0672553
-	I:C0672553
1	I:C0672553
,	O
thereby	O
sensitizing	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
cytotoxicity	I:C0596402
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
of	O
SIRT2	O
requires	O
its	O
ability	O
to	O
restrict	O
the	O
antioxidant	O
activity	I:C1148564
of	O
Prdx	O
-	I:C0672553
1	I:C0672553
,	O
thereby	O
sensitizing	B:C1512505
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
cytotoxicity	I:C0596402
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
of	O
SIRT2	O
requires	O
its	O
ability	O
to	O
restrict	O
the	O
antioxidant	O
activity	I:C1148564
of	O
Prdx	O
-	I:C0672553
1	I:C0672553
,	O
thereby	O
sensitizing	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
cytotoxicity	I:C0596402
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
of	O
SIRT2	O
requires	O
its	O
ability	O
to	O
restrict	O
the	O
antioxidant	O
activity	I:C1148564
of	O
Prdx	O
-	I:C0672553
1	I:C0672553
,	O
thereby	O
sensitizing	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	B:C0012860
DNA	I:C0012860
damage	I:C0012860
and	O
cell	O
cytotoxicity	I:C0596402
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	O
suppressor	I:C1325410
activity	I:C1325410
of	O
SIRT2	O
requires	O
its	O
ability	O
to	O
restrict	O
the	O
antioxidant	O
activity	I:C1148564
of	O
Prdx	O
-	I:C0672553
1	I:C0672553
,	O
thereby	O
sensitizing	O
breast	I:C1512505
cancer	I:C1512505
cells	I:C1512505
to	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
-	O
induced	O
DNA	I:C0012860
damage	I:C0012860
and	O
cell	B:C0596402
cytotoxicity	I:C0596402
.	O

